Ara
Toplam kayıt 46, listelenen: 41-46
The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives
(Informa, 2016-01)
Carbonic anhydrases (CAs, EC 4.2.1.1) had six genetically distinct families described to date in various organisms. There are 16 known CA isoforms in humans. Human CA isoenzymes I and II (hCA I and hCA II) are ubiquitous ...
Synthesis of diaryl ethers with acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase inhibitory actions
(Informa, 2016-12)
A series of diaryl ethers were synthesized and their human (h) carbonic anhydrase (CA) isoenzymes hCA I and II, acetylcholinesterase (AChE), and butyrylcholinesterase (BuChE) inhibitory actions were investigated. The new ...
Synthesis, characterization, molecular docking, and biological activities of novel pyrazoline derivatives
(Wiley, 2019)
In this study, synthesis of ethyl 2‐((4‐bromophenyl)diazenyl)‐3‐oxo‐phenylpropanoate
1 was carried out and a series of new 3H‐pyrazol‐3‐ones (P1–7) were synthesized
from 1 as well as various hydrazines. The obtained ...
Tannic acid as a natural antioxidant compound: Discovery of a potent metabolic enzyme inhibitor for a new therapeutic approach in diabetes and Alzheimer's disease
(Wiley, 2019-03)
Multiple studies have been recorded on the synthesis and design of multi‐aim anti‐Alzheimer molecules. Using dual butyrylcholinesterase/acetylcholinesterase inhibitor molecules has attracted more interest in the therapy ...
Novel eugenol bearing oxypropanolamines: Synthesis, characterization, antibacterial, antidiabetic, and anticholinergic potentials
(Elsevier, 2019-04-16)
Five oxypropanol amine derivatives that four of them are novel have been synthesized with high yields and
practical methods. in vitro antibacterial susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa,
Escherichia ...
Tannic acid as a natural antioxidant compound: Discovery of a potent metabolic enzyme inhibitor for a new therapeutic approach in diabetes and Alzheimer’s disease
(Wiley, 2019-03-25)
Multiple studies have been recorded on the synthesis and design of multi‐aim
anti‐Alzheimer molecules. Using dual butyrylcholinesterase/acetylcholinesterase
inhibitor molecules has attracted more interest in the therapy ...